The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.
SMJ // Article
Original Article
Surgical Treatment of Cardiac Tumors: A Single-Center Experience
Abstract
Objectives: Cardiac tumors affect fewer than 1 in 2000 people. This study is a retrospective review of diagnostic procedures, surgical management, and outcomes in patients treated for tumors of the heart at our institution. We compare our management approaches, clinical, and surgical outcomes with those reported in the literature.Methods: The study population includes patients 7 to 79 years old who presented to our institution for tumors of the heart from July 2004 to January 2023. With institutional review board approval, subjects for this study were identified by searching the hospital’s database on Current Procedural Terminology codes for tumors of the heart (benign neoplasm of the heart or malignant tumor). All of the data were stored on REDCap.
Results: There were 23 men and 29 women in the patient group. The average patient age was 54 years old. The most common presentation symptoms were dyspnea and fatigue. The most common diagnosis methods were transthoracic echocardiogram, transesophageal echocardiogram, cardiac magnetic resonance image, and computed tomography scan. Operative treatment was offered to 52 people; 47 had resection and 5 had biopsy only. The most common postoperative complication was respiratory insufficiency (22) and sepsis (2). Forty-eight patients were diagnosed as having a benign neoplasm of the heart and 4 diagnosed as having a malignant tumor. There were 49 primary tumors and three secondary tumors. The most common location of the tumor was the left atrium. The most common diagnosed cell type for the cardiac tumors was myxoma (61.5%). The average length of stay in the hospital was 12.5 days. Thirty-nine patients were discharged home in a stable condition. The study population had one operative mortality (death within 30 days after surgery). Forty-four of the 52 patients treated are alive after 2 years.
Conclusions: Data from this study strongly suggest that surgical removal is a viable and largely successful treatment approach for cardiac tumors. Clinical outcomes such as discharge status, postoperative condition, and length of survival after procedures are similar to those from other referral centers for such conditions. Complete resection was possible in 90% of our study cases; 85% of patients in this study surgically treated for cardiac tumors are alive after 2 years.
Posted in: Cardiac Tumors1
This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
References
1. Cleveland Clinic. Cardiac tumor: types, symptoms, and treatment. https://my.clevelandclinic.org/health/diseases/22914-cardiac-tumor. Published April 29, 2022. Accessed February 24, 2025.
2. Hoffmeier A, Sindermann JR, Scheld HH, et al. Cardiac tumors—diagnosis and surgical treatment. Dtsch Arztebl Int 2014;111:205–211.
3. Samanidis G, Khoury M, Balanika M, et al. Current challenges in the diagnosis and treatment of cardiac myxoma. Kardiol Pol 2020;78:269–277.
4. Peters PJ, Reinhardt S. The echocardiographic evaluation of intracardiac masses: a review. J Am Soc Echocardiogr 2006;19:230–240.
5. Campisi A, Ciarrocchi AP, Asadi N, et al. Primary and secondary cardiac tumors: clinical presentation, diagnosis, surgical treatment, and results. Gen Thorac Cardiovasc Surg 2022;70:107–115.
6. Restivo L, De Luca A, Fabris E, et al. A 20-year experience in cardiac tumors: a single center surgical experience and a review of literature. J Cardiovasc Med (Hagerstown) 2022;23:722–727.
7. Mkalaluh S, Szczechowicz M, Torabi S, et al. Surgical Treatment of Cardiac Tumors: Insights from an 18-Year Single-Center Analysis. Med Sci Monit 2017;23:6201–6209.
8. Jiang CX, Wang JG, Qi RD, et al. Long-term outcome of patients with atrial myxoma after surgical intervention: analysis of 403 cases. J Geriatr Cardiol 2019;16:338–343.
9. Kacar P, Pavsic N, Bervar M, et al. Cardiac myxoma: single tertiary centre experience. Radiol Oncol 2022;56:535–540.
10. Děrgel M, Gofus J, Smolák P, et al. Surgical treatment of primary cardiac tumors: 20-year single center experience. Kardiochir Torakochirurgia Pol 2022;19:36–40.
11. Lee KS, Kim GS, Jung Y, et al. Surgical resection of cardiac myxoma-a 30-year single institutional experience. J Cardiothorac Surg. 2017;12:18.
12. Matteucci M, Ferrarese S, Mantovani V, et al. Surgical treatment of primary cardiac tumors in the contemporary era: A single-centre analysis. J Card Surg 2021;36:3540–3546.
13. Gošev I, Paić F, Durić Z, et al. Cardiac myxoma the great imitators: comprehensive histopathological and molecular approach. Int J Cardiol 2013;164:7–20.
14. Yanagawa B, Mazine A, Chan EY, et al. Surgery for Tumors of the Heart. Semin Thorac Cardiovasc Surg 2018;30:385–397.
15. Karabinis A, Samanidis G, Khoury M, et al. Clinical presentation and treatment of cardiac myxoma in 153 patients. Medicine (Baltimore) 2018;97:e12397.
16. Gripari P, Pepi M, Fusini L, et al. Cardiac tumors: imaging findings, clinical correlations and surgical treatment in a 15 years single-center experience. J Cardiovasc Surg (Torino) 2022;63: 212–221.
17. Ma H, Niu Y, Tian M, et al. A study of 399 cardiac tumors: characteristics of echocardiography and pathological features. Echocardiography 2022;39:37–45.
18. Strecker T, Rösch J, Weyand M, et al. Primary and metastatic cardiac tumors: imaging characteristics, surgical treatment, and histopathological spectrum: a 10-year-experience at a German heart center. Cardiovasc Pathol 2012;21:436–443.
